2-(2-Methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}ethan-1-one

Catalog No. :
ACNBYO427
CAS No. :
1775462-23-1
Molecular Formula :
C23H25N3O3
Molecular Weight :
391.47

IUPAC Name:2-(2-methoxyphenyl)-1-(4-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)piperidin-1-yl)ethan-1-one

2-(2-Methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$121.00Login to see priceInquiryInquiry
10mg95%$148.00Login to see priceInquiryInquiry
50mg95%$209.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}ethan-1-one
IUPAC Name2-(2-methoxyphenyl)-1-(4-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)piperidin-1-yl)ethan-1-one
MDL No.MFCD28506464
Molecular FormulaC23H25N3O3
Molecular Weight391.47
SMILESO=C(N1CCC(CC2=NC(C3=CC=CC=C3)=NO2)CC1)CC4=CC=CC=C4OC
InChI KeySGCDZDISGHIZMI-UHFFFAOYSA-N
Synonym2-(2-methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}ethan-1-one;Ethanone, 2-(2-methoxyphenyl)-1-[4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-1-piperidinyl]-
CAS No.1775462-23-1

Synthetic Route by SureRoute

1. ACNBYO427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOQKI239 route compound structure diagram
    ACOQKI23993-25-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNBYO427 route product structure diagram
    ACNBYO4271775462-23-1
Inquiry

2. ACNBYO427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCIWT617 route compound structure diagram
    ACCIWT61728033-63-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNBYO427 route product structure diagram
    ACNBYO4271775462-23-1
Inquiry

Comments (0)